Joren Guillaume
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells.
Journal: Scientific reports
Published: June 10, 2024
Strategies to overcome low MHC-I expression in paediatric and adult tumours.
Journal: Immunotherapy advances
Published: July 07, 2023
Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: July 14, 2020
A molecular switch in mouse CD1d modulates natural killer T cell activation by α-galactosylsphingamides.
Journal: The Journal of biological chemistry
Published: June 26, 2019
Synthesis of C6''-modified α-C-GalCer analogues as mouse and human iNKT cell agonists.
Journal: Organic & biomolecular chemistry
Published: February 22, 2017
Galactosylsphingamides: new α-GalCer analogues to probe the F'-pocket of CD1d.
Journal: Scientific reports
Published: December 06, 2016
Autoreactivity to Sulfatide by Human Invariant NKT Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 21, 2016
Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
Journal: Bioorganic & medicinal chemistry
Published: March 06, 2015
The influence of the acyl chain on the transdermal penetration-enhancing effect of synthetic phytoceramides.
Journal: Skin pharmacology and physiology
Published: December 12, 2013
Crystal structures of bovine CD1d reveal altered αGalCer presentation and a restricted A' pocket unable to bind long-chain glycolipids.
Journal: PloS one
Published: August 03, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026